The House Veterans’ Affairs Committee has taken the extraordinary step of voting unanimously to subpoena top leadership at Oracle Health, following a series of contentious developments regarding the Department of Veterans Affairs’ (VA) multi-billion-dollar Electronic Health Record Modernization (EHRM) program. The 19-0 vote targets Oracle CEO Mike Sicilia and Chairman/Chief Technology Officer Larry Ellison, demanding […]
The United States Food and Drug Administration (FDA) has granted approval to Zanvastro (zilganersen), marking a historic milestone as the first-ever therapy for Alexander disease, a rare and devastating neurodegenerative disorder. Developed by Carlsbad-based Ionis Pharmaceuticals, the approval encompasses both pediatric and adult patients, offering a new standard of care for a condition that previously […]
Across Tribal Nations, a multifaceted behavioral health crisis is being met with a transformative approach to recovery that prioritizes cultural identity alongside clinical excellence. Indigenous communities are currently navigating the profound impacts of a crisis rooted in generations of historical trauma, forced displacement, and chronic underinvestment in healthcare infrastructure. As substance use disorder (SUD) and […]
The Strategic Drivers of Summer 2024 M&A Activity The surge in summer deal-making was not incidental but rather a response to several converging economic pressures. According to industry analysts, hospitals have faced sustained labor shortages and inflationary pressures on medical supplies, which have compressed operating margins. By consolidating, systems aim to increase their leverage in […]
Judi Health, a prominent health technology firm and benefits administrator formerly known as Capital Rx, has announced a significant expansion of its clinical partner ecosystem through the integration of three specialized health providers: Color Health, WellTheory, and Cylinder. This strategic move, announced on Thursday, aims to provide employers, unions, and health plans with a more […]
The biopharmaceutical landscape for rare neurological disorders faced a significant setback this week as Ultragenyx Pharmaceutical announced that its late-stage clinical trial for apazunersen, a potential treatment for Angelman syndrome, failed to meet its primary and key secondary endpoints. The announcement, made following the close of market on Wednesday, marks a pivotal moment for the […]
Teva Pharmaceutical Industries has announced successful topline results from a Phase 2a clinical trial evaluating TEV-53408, an experimental anti-IL-15 monoclonal antibody, in patients with celiac disease. The study met its primary endpoint, demonstrating that the drug significantly prevented intestinal damage in patients exposed to gluten compared to those receiving a placebo. This milestone represents a […]
The Nashville-based oncology management platform Thyme Care announced on Wednesday that it has successfully closed a $125 million Series E financing round, a significant milestone that elevates the company’s valuation to over $2 billion. This infusion of capital marks a pivotal moment for the four-year-old organization as it transitions from a specialized care navigation service […]
The landscape of pulmonary diagnostics in the United States is facing a critical bottleneck characterized by high procedural volume and a persistently high rate of complications. Every two minutes, an individual in the U.S. receives a lung cancer diagnosis, a statistic that underscores the urgent necessity for efficient, accurate diagnostic pathways. For the vast majority […]
Healthcare has reached a critical juncture with artificial intelligence, where rapid technological advances are increasingly clashing with stagnant financial and operational outcomes. While the promise of AI to revolutionize medicine is undisputed, many healthcare organizations are finding that their massive investments are failing to yield the expected returns. This disconnect is not necessarily a failure […]
